SCHEMBL30656285

SCHEMBL30656285

N#Cc1cc(C#N)c(N2CCC2)nc1N

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.62
MEN1 O00255 7/20 0.62
KMT2A Q03164 7/20 0.62
RAB9A P51151 5/20 0.62
NPC1 O15118 3/20 0.62
RXFP1 Q9HBX9 3/20 0.62
KDM4E B2RXH2 10/20 0.60
HPGD P15428 4/20 0.60
CASP1 P29466 9/20 0.49
CASP7 P55210 9/20 0.49
ALOX15 P16050 7/20 0.49
HSD17B10 Q99714 6/20 0.49
MAPT P10636 5/20 0.49
TDP1 Q9NUW8 5/20 0.49
TSHR P16473 4/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
NPSR1 Q6W5P4 2/20 0.49
USP2 O75604 1/20 0.49
MAPK1 P28482 3/20 0.48
POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656216 0.97 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL30656049 0.95 ALDH1A1 (0.60) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL30656153 0.85 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL30656237 0.85 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL27883168 0.74 KDM4E (0.57) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL23168043 0.71 CNR2 (0.50) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL30152422 0.71 CNR2 (0.50) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL21561114 0.70 ALDH1A1 (0.66) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL22279004 0.70 CNR2 (0.52) ALDH1A1MEN1KMT2ARAB9ANPC1
SCHEMBL11015453 0.69 CASP1 (0.49) ALDH1A1MEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447962-A1 ADENOSINE 2A RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF CANCER UNIVERSITE DE GENEVE (CH) 2024-10-23 EP disclosed
WO-2023213761-A1 ADENOSINE 2A RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF CANCER UNIVERSITE DE GENEVE (CH) 2023-11-09 WO disclosed